Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px
Document › Details

Themis Bioscience N.V.. (10/29/18). "Press Release: Themis Bioscience Launches its Initial Public Offering on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna.

Organisations Organisation Themis Bioscience N.V.
  Group Themis Bioscience (Group)
  Organisation 2 Euronext Amsterdam N.V.
  Group Euronext (Group)
Product Product  investment banking
Index term Index term Themis Bioscience–SEVERAL: investment, 201810– IPO €35m to €55.3m on Euronext Amsterdam POSTPONED 11/18
Persons Person Tauber, Erich (Themis Bioscience GmbH 201505 CEO)
  Person 2 Zettlmeissl, Gerd (Intercell 2005–201105 CEO before COO since 2001 before Chiron Behring before Behringwerke)
     


   
Record changed: 2018-11-12

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px

More documents for Themis Bioscience (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px




» top